Addition of statins to the standard treatment in patients with cirrhosis: Safety and efficacy
Authors:
- Alberto E MuñozAMAlberto E Muñoz
- Florencia D PollarskyFPFlorencia D Pollarsky
- Mónica MarinoMMMónica Marino
- Mariano CartierMCMariano Cartier
- Horacio VázquezHVHoracio Vázquez
- Pablo SalgadoPSPablo Salgado
- Gustavo RomeroGRGustavo Romero
Open Access
- 28 July 2021
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 27 (28) , 4639-4652
Abstract
Addition of statins to the standard treatment in patients with cirrhosis: Safety and efficacyKeywords
This publication has 68 references indexed in Scilit:
- Association of Liver Stiffness with Hepatic Expression of Pharmacokinetically Important Genes in Alcoholic Liver DiseaseAlcohol, Clinical and Experimental Research, 2012
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- Drug-Induced Liver Injury Associated with StatinsSeminars in Liver Disease, 2009
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine, 2008
- SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide StudyNew England Journal of Medicine, 2008
- Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthaseHepatology, 2007
- Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic ratsJournal of Hepatology, 2007
- PLEIOTROPIC EFFECTS OF STATINSAnnual Review of Pharmacology and Toxicology, 2005
- Dose Adjustment in Patients with Liver DiseaseDrug Safety, 2005
- Design features and baseline characteristics of the LIPID (long-term intervention with pravastatin in ischemic disease) study: A randomized trial in patients with previous acute myocardial infarction and/or unstable angina pectorisThe American Journal of Cardiology, 1995